...
首页> 外文期刊>Journal of refractive surgery >Deep Intrastromal Arcuate Keratotomy With In Situ Keratomileusis (DIAKIK) for the Treatment of High Astigmatism After Keratoplasty: 2-Year Follow-up.
【24h】

Deep Intrastromal Arcuate Keratotomy With In Situ Keratomileusis (DIAKIK) for the Treatment of High Astigmatism After Keratoplasty: 2-Year Follow-up.

机译:深度科技弧形角辐射术与原位角膜瘤(Diakik)治疗角膜膜术后高散光:2年后续随访。

获取原文
获取原文并翻译 | 示例
           

摘要

To describe 2-year results of deep intrastromal arcuate keratotomy with in situ keratomileusis (DIAKIK) for the treatment of high astigmatism after keratoplasty. This prospective study included 20 eyes from 20 patients presenting with high astigmatism after keratoplasty. All were treated by two-step femtosecond laser surgery, with two intrastromal arcuate keratotomies and a corneal flap, followed a few months later by excimer photoablation after reopening of the flap. At 24 months, both uncorrected (UDVA) and corrected (CDVA) distance visual acuity had improved from 1.12 ± 0.42 logMAR (20/200 Snellen) before surgery to 0.58 ± 0.23 logMAR (20/80 Snellen) (P < .001) and from 0.31 ± 0.26 logMAR (20/40 Snellen) to 0.20 ± 0.20 logMAR (20/32 Snellen) (P = .04), respectively. The mean spherical equivalent improved from -5.01 ± 4.35 to -1.54 ± 2.42 diopters. The mean efficacy index was 0.63. The mean correction index was 0.93 ± 0.32. The mean flattening index was 1.09 ± 0.75 and the mean safety index was 1.39. No graft rejection or epithelial ingrowth was observed. This two-step procedure was an effective treatment for high astigmatism after keratoplasty. The use of both femtosecond and excimer lasers helped to avoid some complications that would have jeopardized the grafts. Refractive and topographic stability was good 2 years after surgery. [J Refract Surg. 2019;35(4):239-246.].
机译:描述在静脉成形术后的原位角膜瘤(Diakik)中对Soutu Keratomileusis(Diakik)的深度科技弧形角辐射术的2年结果。这项前瞻性研究包括20名患者的20只眼睛,在角膜形成术后呈现出高度散光。所有经过两步飞秒激光手术治疗,两位科学弧形角质表术和角膜皮瓣,在再打开襟翼后,几个月后几个月就在折叠后的拍摄。在24个月之前,未经校正(UDVA)和校正(CDVA)距离视力从手术前的1.12±0.42 logmar(20/200 snellen)提高到0.58±0.23 logmar(20/80 snellen)(p <.001)和从0.31±0.26 logmar(20/40 snellen)分别为0.20±0.20 logmar(20/32 snellen)(p = .04)。平均球形等效物从-5.01±4.35至-1.54±2.42屈光度提高。平均疗效指数为0.63。平均校正指数为0.93±0.32。平均扁平指数为1.09±0.75,平均安全指数为1.39。没有观察到移植物抑制或上皮内直肠。这种两步的程序是在角膜术后高散光的有效治疗。使用Femtosecond和准分子激光器有助于避免一些将危及移植物的并发症。手术后2年屈光和地形稳定性好。 [j屈服surg。 2019; 35(4):239-246。]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号